IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease
Zhou, Junhua; Zhang, Yimiao; Liu, Gang; Li, Jun; Xu, Rong; Huang, Jing
关键词leflunomide minimal change disease nephrotic syndrome steroid-dependent steroid-resistant
刊名CLINICAL NEPHROLOGY
2013-08-01
DOI10.5414/CN107723
80期:2页:121-129
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Urology & Nephrology
资助者Project 985 ; Program for Changjiang Scholars and Innovative Research Team in University ; Project 985 ; Program for Changjiang Scholars and Innovative Research Team in University
研究领域[WOS]Urology & Nephrology
关键词[WOS]CHANGE NEPHROTIC SYNDROME ; MYCOPHENOLATE-MOFETIL ; RITUXIMAB THERAPY ; CYCLOSPORINE ; NEPHROPATHY ; TRIAL
英文摘要

Objective: To observe the efficacy and safety of leflunomide combined with prednisone therapy (LEF therapy) in the treatment of patients with adult onset steroid-dependent and steroid-resistant minimal change disease (MCD). Methods: 16 MCD patients who had been treated with LEF therapy were retrospectively analyzed. 87.5% (14/16) of the patients were steroid-dependent and 12.5% (2/16) of the patients were steroid-resistant. The initial dose of LEF was 10 - 20 mg/day combined with prednisone 0.25 - 1.0 mg/kg/day, gradually tapering after 8 weeks. Clinical and laboratory data at baseline, 2nd, 4th, 8th, 12th, 24th, and 48th week were analyzed compared with initial course of prednisone monotherapy (FRED monotherapy) and cyclophosphamide combined with prednisone therapy (CTX therapy). Results: All the 16 patients achieved different levels of remission in LEF therapy. 93.8% (15/16) of the patients, including the two steroid-resistant patients, achieved complete remission. During the treatment, 8 patients had adverse effects which could be well tolerated. Compared LEF therapy with PRED monotherapy (n = 16), the dose of prednisone to maintain remission was reduced (from median 22.5 mg/day to median 7.5 mg/day, p = 0.041); relapse rate during the follow-up decreased from 100% to 31.3% (p = 0.002); the median time before relapse increased from 20.3 weeks to 32.5 weeks. Compared LEF therapy with CTX therapy (n = 12), the dose of prednisone to maintain remission was reduced significantly (from median 22.5 mg/day to median 5.0 mg/day, p = 0.003); relapse rate during the follow-up decreased from 100% to 31.3% (p = 0.001); the median time before relapse increased from 11.7 weeks to 32.5 weeks. Conclusions: LEF therapy seems to be effective in steroid-resistant and steroid-dependent MCD. This therapy may reduce the amount of preclnisone to maintain remission and reduce the relapse rate compared with PRED monotherapy and CTX therapy. LEF therapy was usually well tolerated.

语种英语
所属项目编号985-2-033-39 ; IRT0803
资助者Project 985 ; Program for Changjiang Scholars and Innovative Research Team in University ; Project 985 ; Program for Changjiang Scholars and Innovative Research Team in University
WOS记录号WOS:000323990000006
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60971
专题北京大学第一临床医学院
作者单位Peking Univ, Hosp 1, Minist Hlth China, Renal Div,Dept Med,Inst Nephrol,Key Lab Renal Dis, Beijing 100034, Peoples R China
推荐引用方式
GB/T 7714
Zhou, Junhua,Zhang, Yimiao,Liu, Gang,et al. Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease[J]. CLINICAL NEPHROLOGY,2013,80(2):121-129.
APA Zhou, Junhua,Zhang, Yimiao,Liu, Gang,Li, Jun,Xu, Rong,&Huang, Jing.(2013).Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.CLINICAL NEPHROLOGY,80(2),121-129.
MLA Zhou, Junhua,et al."Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease".CLINICAL NEPHROLOGY 80.2(2013):121-129.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhou, Junhua]的文章
[Zhang, Yimiao]的文章
[Liu, Gang]的文章
百度学术
百度学术中相似的文章
[Zhou, Junhua]的文章
[Zhang, Yimiao]的文章
[Liu, Gang]的文章
必应学术
必应学术中相似的文章
[Zhou, Junhua]的文章
[Zhang, Yimiao]的文章
[Liu, Gang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。